Online Doctor Consultation & Medicines
Back ArrowBack Arrow
Offer IconSpecial offers
  1. Home
  2. MEGAVOG MF 0.2MG/500MG TABLET

MEGAVOG MF 0.2MG/500MG TABLET

Manufacturer

Aristo Pharmaceuticals Pvt Ltd

Composition

METFORMIN-500MG + VOGLIBOSE-0.2MG

Pack Of

10 TABLETS

In Stock

Prescription Required
Product Details

About MEGAVOG MF 0.2MG/500MG TABLET

MEGAVOG MF 0.2MG/500MG TABLET belongs to the class of anti-diabetic drugs. It is used in the treatment of type 2 diabetes mellitus. Diabetes mellitus is a metabolic disease that causes high blood sugar levels. It occurs when the insulin (a hormone produced by the beta cells of the pancreas) is resistant in breaking the glucose to produce energy (insulin resistance) or the pancreas (an organ behind the stomach) produces little or no insulin at all.

MEGAVOG MF 0.2MG/500MG TABLET is composed of two medicines, namely voglibose and metformin. Voglibose belongs to the class of alpha-glucosidase inhibitors. It is used in the treatment of diabetes mellitus and acts by delaying glucose absorption. Metformin belongs to the class of biguanides and is used to manage blood sugar levels, particularly in obese patients.

Voglibose acts by inhibiting the intestinal enzymes, which break complex sugars into simple sugars such as glucose. This process prevents the rise of blood glucose levels. Metformin exhibits non pancreatic effect to reduce serum glucose levels without increasing insulin secretion. It is also known as an insulin sensitizer as it increases the effects of insulin. Metformin is considered to be a unique anti-diabetic drug since it does not cause hypoglycemia (lowered blood sugar levels).

MEGAVOG MF 0.2MG/500MG TABLET is an orally administered drug. Take this drug with food at regular intervals as prescribed by your doctor to avoid stomach upset. Do not crush, chew or break the tablet. Your doctor will decide the dosage form, and this may change timely depending on your blood sugar levels. Do not stop taking MEGAVOG MF 0.2MG/500MG TABLET on your own, since it may cause a rise in your blood sugar levels leading to other health issues like kidney damage, blindness and loss of limbs. The common side effects of MEGAVOG MF 0.2MG/500MG TABLET include nausea, vomiting, changes in taste, diarrhea, dizziness, stomach pain, shortness of breath, skin rash, bloating, and flatulence (intestinal wind/gas). Although not everyone experiences these side effects, if they occur, seek medical attention.

Before starting MEGAVOG MF 0.2MG/500MG TABLET, let your doctor know if you have any medical history of anaemia (low hemoglobin levels), seizures (fits), heart, kidney, and liver diseases. MEGAVOG MF 0.2MG/500MG TABLET does not cause hypoglycemia (low blood sugar levels). However, when used with other diabetic drugs like insulin or sulfonylureas, it can lead to hypoglycemia. Also, speak to your doctor if you are on restricted food or fluid intake since MEGAVOG MF 0.2MG/500MG TABLET causes dehydration, low blood sugar, and kidney damage. Do not take MEGAVOG MF 0.2MG/500MG TABLET if you have gastrointestinal diseases like ulcerative colitis or Crohn’s disease. Do not take or stop MEGAVOG MF 0.2MG/500MG TABLET, if the doctor did not advise you to do so.

Uses of MEGAVOG MF 0.2MG/500MG TABLET

Type 2 Diabetes mellitus 

Directions for Use

MEGAVOG MF 0.2MG/500MG TABLET is available as an oral tablet formulation. Your doctor prescribes the dosage based on your disease conditions and tolerance. Do not chew, crush or break the tablet and swallow it as a whole with a glass of water. Take MEGAVOG MF 0.2MG/500MG TABLET preferably with a meal, since it lowers the blood sugar levels and causes gastrointestinal side effects. Your doctor may start the course with a low dose and gradually maintain an effective dose to achieve the required blood glucose control.

Storage

Store in a cool and dry place away from sunlight

Side Effects of MEGAVOG MF 0.2MG/500MG TABLET

Most of the side effects of MEGAVOG MF 0.2MG/500MG TABLET do not require medical attention and gradually resolve over time. MEGAVOG MF 0.2MG/500MG TABLET can cause common side effects like nausea, vomiting, changes in taste, diarrhea, dizziness, stomach pain, shortness of breath, skin rash, bloating, and flatulence (intestinal wind/gas). Seek medical advice if these side effects persist longer.

Some less common side effects of MEGAVOG MF 0.2MG/500MG TABLET include pneumatosis intestinalis (gas-filled cysts on the bowel wall) when used along with other alpha-gastrointestinal drugs and lactic acidosis (a rare, but serious metabolic complication of excess lactic acid in the blood that is caused by metformin accumulation).

The risk of lactic acidosis is high in people with kidney, liver, and heart diseases. It is essential to speak to your doctor about your medical history before you take MEGAVOG MF 0.2MG/500MG TABLET. If any of these side effects occur and persist longer, call your doctor for emergency treatment.

In-Depth Precautions and Warning

Drug Warning

MEGAVOG MF 0.2MG/500MG TABLET may increase the risk of cardiovascular diseases and hypoglycemic conditions in renal and liver disease patients. It can cause pneumatosis intestinalis (gas-filled cysts on the bowel wall) when used along with other alpha-gastrointestinal drugs. It is advised to monitor the gastrointestinal side effects thoroughly to rule out the possibility of pneumatosis intestinalis.

MEGAVOG MF 0.2MG/500MG TABLET has an increased risk of lactic acidosis (a rare, but serious metabolic complication of excess lactic acid in the blood that is caused by metformin accumulation). The risk of lactic acidosis is high in older people with kidney, liver, and heart diseases. Hence, brief your medical history and take advice from your doctor before starting MEGAVOG MF 0.2MG/500MG TABLET. Avoid consuming excessive alcohol as it can potentiate lactic acidosis.

Safety Advice

  • Alcohol

    Consult Your Doctor

    It is unsafe to consume alcohol since it may worsen the side effects.

  • Pregnancy

    MEGAVOG MF 0.2MG/500MG TABLET may cause a risk in pregnancy. Please consult your doctor before starting MEGAVOG MF 0.2MG/500MG TABLET.

  • Breast Feeding

    There is no sufficient data on how MEGAVOG MF 0.2MG/500MG TABLET affects breastfeeding. It is safe to seek medical advice before you start MEGAVOG MF 0.2MG/500MG TABLET if you are lactating.

  • Driving

    Your driving ability may be affected if your blood sugar levels are too high or too low. Do not drive or operate machinery if you also experience dizziness or drowsiness.

  • Liver

    Let your doctor know if you have any history of liver diseases or hepatic impairment when you are prescribed MEGAVOG MF 0.2MG/500MG TABLET.

  • Kidney

    Let your doctor know if you have any history of kidney diseases when you are prescribed MEGAVOG MF 0.2MG/500MG TABLET.

Other Information (MEG0281)

This item is Not Returnable.

Expires on or after - September 2021

Patients Concern

FAQs

Oral administration of MEGAVOG MF 0.2MG/500MG TABLET decreases blood sugar levels. Hence, it is advised to take MEGAVOG MF 0.2MG/500MG TABLET with a meal.

There is no evidence of MEGAVOG MF 0.2MG/500MG TABLET, causing weight loss. However, high doses of medicine affect food absorption, thereby causing a weight loss. Consult your doctor before starting MEGAVOG MF 0.2MG/500MG TABLET.

MEGAVOG MF 0.2MG/500MG TABLET can cause risk in pregnancy and affect the fetus. Please consult your doctor before starting MEGAVOG MF 0.2MG/500MG TABLET.

There is no sufficient data on how MEGAVOG MF 0.2MG/500MG TABLET affects breastfeeding. It is safe to seek medical advice before you start MEGAVOG MF 0.2MG/500MG TABLET if you are lactating.

It is unsafe to consume alcohol since it may worsen the side effects.

Do not stop taking MEGAVOG MF 0.2MG/500MG TABLET until your prescribed course is finished, even if you feel better.

Take the missed dose as soon as possible. However, if it is time for the next dose, skip the missed dose and go back to your regular dosing schedule.

Your driving ability may be affected if your blood sugar levels are too high or too low. Do not drive or operate machinery if you also experience dizziness or drowsiness.

Manufacturer/Marketer address

Mercantile Chamber, 3rd Floor, 12, J.N. Heredia Marg, Ballard Estate, Mumbai – 400 001, India.

MEGAVOG MF 0.2MG/500MG TABLET

MEGAVOG MF 0.2MG/500MG TABLET

MRP: 58.65

Strip
1

10 Tablet in 1 Strip